Product information and disease descriptionProduct descriptionProduct information
Product comparison
1 evidence topic · 1 source
Treatment alternatives: eteplirsen prescribing information
| Product-information element | Direct quotation |
|---|---|
| Mutation requirement | “amenable to exon 51 skipping” |
| Dose | “30 milligrams per kilogram of body weight once weekly” |
| Administration | “intravenous infusion over 35 to 60 minutes” |
Head-to-head comparison with an approved therapy
No evidence found.